This article was reviewed by Darragh O’Carroll, MD. GLP-1 for Weight Loss: Everything You Need to Know Key takeaways: GLP-1s ...

This article was reviewed by Darragh O’Carroll, MD. Diabetes Medications for Weight Loss: What to Know Key takeaways: Some ...

The FDA's approval of the glucagon-like peptide receptor agonist marks the first non-insulin drug approved for youth with type 2 diabetes since the approval of metformin for pediatric use in 2000.

Liraglutide is an injectable prescription medicine used: along with diet and exercise to lower blood sugar (glucose) in adults and children who are 10 years of age and older with type 2 diabetes ...

SAN FRANCISCO —The glucagon-like peptide-1 (GLP-1) agonist liraglutide (Victoza, Novo Nordisk) taken every day preserved postprandial insulin secretion for 1 year after type 1 diabetes diagnosis in ...

Adults with type 2 diabetes at high cardiovascular risk have a lower risk for pancreatitis when treated with liraglutide compared with placebo, according to findings published in Diabetes Care.

January 26, 2010 — Liraglutide injection (Victoza, Novo Nordisk) was approved yesterday by the US Food and Drug Administration (FDA) for the treatment of type 2 diabetes in adults. Liraglutide is the ...

Please provide your email address to receive an email when new articles are posted on . In patients with type 2 diabetes but usually not heart disease, liraglutide had better CV outcomes vs. some ...

The addition of liraglutide, a glucagon-like peptide-1 receptor agonist, to metformin with or without basal insulin, improves glycemic control in children and adolescents with type 2 diabetes. The ...

A TLANTA -- Women who had been taking GLP-1 receptor agonist medications prior to becoming pregnant had a lower risk of ...

Branded content furnished by our promotional partners. The Daily Sundial editorial staff is not involved in its production. Content does not reflect the views or opinions of the editorial staff.

Now, Cleveland Clinic researchers may have figured out which patients have the best odds of success. Women who take Wegovy to treat obesity have the greatest likelihood of achieving 10% or more weight ...